David Goetz provides counseling and strategic advice to emerging and established companies in the biotechnology and pharmaceutical industries. He advises clients on domestic and international patent matters, including patent protection and enforcement, freedom-to-operate, intellectual property due diligence, and analysis of third-party patents.
David’s experience includes preparing, prosecuting, and enforcing patent rights in the biotechnology and related fields. He has experience with large-molecule therapeutics and diagnostics, cell-based therapeutics, small-molecules, transgenic plants and animals, high-throughput sequencing, gene-editing techniques, and other protein and nucleic acid-based technologies. He also has experience with medical and mechanical devices and methods of their manufacture.
David has published peer-reviewed scientific papers related to genetic mapping of traits in the plant A. thaliana, structural and biochemical characterization of proteins of the mammalian immune system, structure-based drug design of anti-viral small-molecule compounds, and development and characterization of antibodies that bind novel cancer-related targets. He is a co-inventor on one issued patent related to his antibody work.